Aprea Therapeutics, Inc. (APRE)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

$32.16K Net Amount

Buy:	$32.16K	$2.54 - $2.90
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

22

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Oct-24 8:31 AM View:	11-Oct-24 Market Purchase $26.80K	Seizinger Bernd R. Director		Aprea Therapeutics, Inc. - APRE	67% 26.82K to 44.73K	$26.80K 37%	0	$2.68	--	Show Txns Hide Txns

14-Mar-24 8:52 PM View:	13-Mar-24 Purchase $50.01K	Henneman John B III Director		Aprea Therapeutics, Inc. - APRE	536% 1.28K to 8.14K	0	0	--	--	Show Txns Hide Txns

16-Oct-24 8:30 AM View:	14-Oct-24 Market Purchase $0.49K	Duey Marc Director		Aprea Therapeutics, Inc. - APRE	0% 210.53K to 210.72K	$0.49K	0	$2.58	--	Show Txns Hide Txns

16-Oct-24 8:30 AM View:	11-Oct-24 Private Purchase $0.12K	Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr		Aprea Therapeutics, Inc. - APRE	34% 14.49K to 19.37K	$1.17K 3%	0	$2.61	--	Show Txns Hide Txns

02-May-24 4:16 PM View:	01-May-24 Grant 0	Mirza Nadeem Q. Chief Medical Officer		Aprea Therapeutics, Inc. - APRE	100% 0 to 6.73K	0	0	--	--	Show Txns Hide Txns

16-Oct-24 8:31 AM View:	15-Oct-24 Market Purchase $0.72K	Gilad Oren President/CEO Director		Aprea Therapeutics, Inc. - APRE	4% 322.77K to 334.69K	$3.70K	0	$2.54 - $2.90	--	Show Txns Hide Txns